{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:55:34Z","timestamp":1792454134297,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Immunoglobulin M multiple myeloma and Waldenstr\u00f6m macroglobulinemia are two different hematological diseases with the common finding of an immunoglobulin M monoclonal gammopathy of unknown significance. However, clinical characteristics of the two entities can overlap.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>In this report, we describe two cases of immunoglobulin M neoplasm with the same histological bone marrow presentation but with different clinical behavior, cytogenetics, and biological assessment. On the basis of comprehensive diagnostic workup, these patients were considered to have different diseases and treated accordingly with different approaches. Patient 1 (Caucasian man) presented with increased serum protein and immunoglobulin M (7665\u2009mg\/L) with an M-spike electrophoresis of 4600\u2009mg\/L. His bone marrow biopsy revealed a small-cell immunoglobulin M multiple myeloma. The result of testing for the MYD88 L265P mutation was negative, while fluorescence <jats:italic>in situ<\/jats:italic> hybridization analysis showed translocation t(11,14). A diagnosis of immunoglobulin M-\u03ba multiple myeloma was made. Patient 1 was a candidate for bortezomib plus thalidomide and dexamethasone, followed by autologous stem cell transplant consolidation. Patient 2 (Caucasian man) showed an M-spike by protein electrophoresis (300\u2009mg\/L, 4.9%), with serum immunoglobulin M level of 327\u2009mg\/L. His bone marrow biopsy revealed immunoglobulin M-\u03ba multiple myeloma. Computed tomography showed many enlarged lymph nodes and splenomegaly. Patient 2\u2019s clinical features were suggestive of Waldenstr\u00f6m macroglobulinemia, in contrast to the bone marrow biopsy results. The result of testing for the MYD88 L265P mutation was positive. Patient 2 was diagnosed with Waldenstr\u00f6m macroglobulinemia and received rituximab, cyclophosphamide, and dexamethasone.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>A correct differential diagnosis between immunoglobulin M multiple myeloma and Waldenstr\u00f6m macroglobulinemia is a critical point in the setting of a new immunoglobulin M monoclonal gammopathy onset. These patients should undergo a complete diagnostic workup with pathological, radiological, and serological examinations to establish the diagnosis and plan the most appropriate treatment in order to improve the prognosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13256-020-02380-2","type":"journal-article","created":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T23:02:43Z","timestamp":1592780563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immunoglobulin M (IgM) multiple myeloma versus Waldenstr\u00f6m macroglobulinemia: diagnostic challenges and therapeutic options: two case reports"],"prefix":"10.1186","volume":"14","author":[{"given":"Simona","family":"Elba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Castellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Soriasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Castellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Bonferroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Strola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Drandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Mordini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Foglietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Rapezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Celeghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Fraternali Orcioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Massaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"2380_CR1","volume-title":"Multiple myeloma: clinical features, laboratory manifestations, and diagnosis","author":"JP Laubach","year":"2017","unstructured":"Laubach JP. In: Post TW, editor. Multiple myeloma: clinical features, laboratory manifestations, and diagnosis. Waltham: UpToDate; 2017."},{"issue":"1","key":"2380_CR2","doi-asserted-by":"publisher","first-page":"107327481774444","DOI":"10.1177\/1073274817744448","volume":"25","author":"FJ Bonilla-Valent\u00edn","year":"2018","unstructured":"Bonilla-Valent\u00edn FJ, Cerra J, C\u00e1ceres-Perkins W, Alsina M. Case report of IgM multiple myeloma: diagnosing a rare hematologic entity. Cancer Control. 2018;25(1):1073274817744448.","journal-title":"Cancer Control"},{"issue":"11","key":"2380_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/ajh.21845","volume":"85","author":"SR Schuster","year":"2010","unstructured":"Schuster SR, Rajkumar SV, Dispenzieri A, et al. IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstr\u00f6m\u2019s macroglobulinemia. Am J Hematol. 2010;85(11):853\u20135. 3.","journal-title":"Am J Hematol"},{"key":"2380_CR4","volume-title":"Epidemiology, pathogenesis, clinical manifestations, and diagnosis of Waldenstr\u00f6m macroglobulinemia","author":"SM Ansell","year":"2017","unstructured":"Ansell SM. In: Post TW, editor. Epidemiology, pathogenesis, clinical manifestations, and diagnosis of Waldenstr\u00f6m macroglobulinemia. Waltham: UpToDate; 2017."},{"key":"2380_CR5","doi-asserted-by":"publisher","unstructured":"Cilla N, Vercruyssen M, Ameye L, et al. Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation [in French]. Rev Med Brux. 2018. https:\/\/doi.org\/10.30637\/2018.17-090.","DOI":"10.30637\/2018.17-090"},{"issue":"4","key":"2380_CR6","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2002-08-2436","volume":"101","author":"HA Louiseau","year":"2003","unstructured":"Louiseau HA, Grand R, Lode L, Harousseau JL, Bataille R. Intergroupe Francophone du Myelome. Translocation t(11,14)(q13; q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood. 2003;101(4):1570\u20131.","journal-title":"Blood."},{"key":"2380_CR7","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/ajh.24753","volume":"92","author":"JJ Castillo","year":"2017","unstructured":"Castillo JJ, Jurczyszyn A, Brozova L, et al. IgM myeloma: a multicenter retrospective study of 134 patients. Am J Hematol. 2017;92:746\u201351.","journal-title":"Am J Hematol"},{"issue":"Suppl 4","key":"2380_CR8","doi-asserted-by":"publisher","first-page":"iv41","DOI":"10.1093\/annonc\/mdy146","volume":"29","author":"E Kastritis","year":"2018","unstructured":"Kastritis E, Leblond V, Dimopoulos MA, et al. Waldenstr\u00f6m\u2019s macroglobulinaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv41\u201350. Published corrections appear in Ann Oncol. 2018;29(Suppl 4):iv270; Ann Oncol. 2019;30(5):860\u20132.","journal-title":"Ann Oncol"},{"key":"2380_CR9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMc1506192","volume":"373","author":"SP Treon","year":"2015","unstructured":"Treon SP, Xu L, Hunter Z. MYD88 mutation and response to ibrutinib in Waldenstr\u00f6m\u2019s macroglobulinemia. N Engl J Med. 2015;373:584\u20136.","journal-title":"N Engl J Med"},{"issue":"14","key":"2380_CR10","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","volume":"376","author":"M Attal","year":"2017","unstructured":"Attal M, Lauwers-Cances V, Hulin C, et al. Lenalidomide, bortezomib and dexamethasone with transplantation for myeloma. N Engl J Med. 2017;376(14):1311\u201320.","journal-title":"N Engl J Med"},{"issue":"8","key":"2380_CR11","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1182\/blood-2006-02-005488","volume":"108","author":"WJ Chng","year":"2006","unstructured":"Chng WJ, Schop RF, Price-Troska T, et al. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood. 2006;108(8):2755\u201363.","journal-title":"Blood"},{"key":"2380_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","volume":"381","author":"MJ Rummel","year":"2013","unstructured":"Rummel MJ, Niederle N, Maschmeyer G, et al. Bendamustine plus rituximab versus CHOP plus rituximab as first line treatment for patients with indolent and mantle cell lymphomas: an open label, multicenter, randomized, phase III non inferiority trial. Lancet. 2013;381:1203\u201310.","journal-title":"Lancet"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02380-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-020-02380-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02380-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T23:48:47Z","timestamp":1624319327000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-020-02380-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2380"],"URL":"https:\/\/doi.org\/10.1186\/s13256-020-02380-2","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"6 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The data were collected in accordance with the Declaration of Helsinki and good clinical practice guidelines. All patients provided written informed consent to publication of their data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}